Shares of biopharma company Corcept Therapeutics (NASDAQ:CORT) fell 9.2% in the afternoon session after investment bank UBS initiated coverage of the company with a Neutral rating.
Bank of America analysts have projected a potentially sharp acceleration in earnings growth for UBS Group AG , positioning ...
In its fiscal Q4 2025 report, Analog Devices, Inc. (NASDAQ:ADI) showed solid growth. Revenue and earnings per share both came ...
DETROIT -- Taking the ice in front of Hockeytown faithful for the first time in two weeks, the Detroit Red Wings will open a ...
Through its acquisition of HanesBrands, Gildan Activewear (GIL) can now achieve the size and scale it couldn’t do on its own, ...
Find insight on PayPal, UBS, Bridgepoint, the Singapore Exchange and more in the latest Market Talks covering Financial ...
Mike Dargan, who starts in April, had served as the Swiss bank’s chief operations and technology officer. His hire ends a ...
N26 has endured a rocky few months owing to reported investor unrest.
UBS' chief operations and technology officer, Mike Dargan, will leave the Swiss bank at the end of the month, the company ...
Offered exclusively through Carahsoft Technology Corp., Zoom for Defense includes capabilities such as Zoom AI Companion, ...
UBS said its chief operations and technology officer, Mike Dargan, is to leave the Swiss banking giant as it continues a leadership reshuffle. The news of Dargan's departure comes after UBS in October ...
Shares of Dollar General (NYSE: DG) are up another $3.80 a share in premarket. All as it continues to gap higher on strong ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback